Normal muscle enzyme levels in classic dermatomyositis: implications for clinical trial endpoints
- 24 July 2025
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (4) , 779-781
Abstract
Muscle involvement in dermatomyositis can present without muscle enzyme elevations in 26–48% of patients. These findings are important to acknowledge in order to interpret muscle enzyme testing within the broader clinical context.Keywords
Funding Information
- National Institutes of Health-USA (R01AR076766)
- United States Department of Veterans Affairs Merit Review (BX005921-01)
This publication has 8 references indexed in Scilit:
- Development and Evaluation of the Dermatomyositis Outcomes for Muscle and Skin as an Outcome Measure in Dermatomyositis Clinical TrialsJID Innovations, 2024
- Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective databaseJournal of the American Academy of Dermatology, 2024
- Disease spectrum of myopathies with elevated aldolase and normal creatine kinaseEuropean Journal of Neurology, 2023
- Dermatomyositis: Clinical features and pathogenesisJournal of the American Academy of Dermatology, 2020
- 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositisAnnals of the Rheumatic Diseases, 2017
- Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementFrontiers in Neurology, 2016
- Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: Dermatomyositis sine myositis?Journal of the American Academy of Dermatology, 1993
- A COMPUTER-ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITISMedicine, 1977